Last edition
News about "chronic therapies "
Crisil Projects 11-13 Percent Revenue Growth for Indian Pharma Sector
India’s pharmaceutical sector is projected to grow 11-13 percent in revenue this fiscal, supported by exports and domestic demand, according to Crisil Ratings.
Chronic Therapies | 24/09/2026 | By News Bureau
Innovation Led Growth Dominates Indian Pharma Market in 2025
The India’s pharmaceutical market grew 10.6 percent year-on-year in December 2025, driven by chronic therapies, GLP-1 drugs, and strong innovation-led demand.
Chronic Therapies | 15/01/2026 | By News Bureau | 1448
Innovation Led Growth Dominates Indian Pharma Market in 2025
The India’s pharmaceutical market grew 10.6 percent year-on-year in December 2025, driven by chronic therapies, GLP-1 drugs, and strong innovation-led demand.
Chronic Therapies | 15/01/2026 | By News Bureau | 1448
AstraZeneca Plans USD 2 Billion Manufacturing Investment in Maryland
AstraZeneca will invest USD 2 billion to expand its biologics manufacturing in Maryland, boosting production of cancer, rare disease, and chronic therapies while supporting around 2,600 jobs.
Chronic Therapies | 24/11/2025 | By Dineshwori | 219
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy